{"date":"2025-05-19","count":15,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6885-2025-05-19-1934-1bvflzs","company_id":"6885","company":"全福生技","market":"上市","industry":"生技醫療","date":"2025-05-19","time":"19:34:49","subject":"公告本公司開發中新藥BRM421已向美國食品藥物管理局(US FDA)提出治療乾眼症第II期劑量探索、安全性與療效性之臨床試驗申請","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：全福生技（6885），2025-05-19 19:34，「公告本公司開發中新藥BRM421已向美國食品藥物管理局(US FDA)提出治療乾眼症第II期劑量探索、安全性與療效性之臨」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2025-05-19-1922-1upgtjv","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-19","time":"19:22:04","subject":"公告本公司眼藥水治療乾燥症病人眼角膜破損二期臨床實驗初步結果","clause":"第8款","fact_date":"2025-05-19","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2025-05-19 19:22，「公告本公司眼藥水治療乾燥症病人眼角膜破損二期臨床實驗初步結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6838-2025-05-19-1920-m7rsdv","company_id":"6838","company":"台新藥","market":"上市","industry":"生技醫療","date":"2025-05-19","time":"19:20:01","subject":"公告本公司授權夥伴向沙烏地阿拉伯食品藥物管理局申請眼部術後炎症和疼痛治療新藥APP13007上市查驗登記","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台新藥（6838），2025-05-19 19:20，「公告本公司授權夥伴向沙烏地阿拉伯食品藥物管理局申請眼部術後炎症和疼痛治療新藥APP13007上市查驗登記」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6918-2025-05-19-1731-ij1k23","company_id":"6918","company":"愛派司","market":"上市","industry":"生技醫療","date":"2025-05-19","time":"17:31:19","subject":"修正募資計畫專區現金增資基本資料(每股發行價格誤植為面額)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：愛派司（6918），2025-05-19 17:31，「修正募資計畫專區現金增資基本資料(每股發行價格誤植為面額)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2025-05-19-1659-67rslk","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2025-05-19","time":"16:59:18","subject":"公告本公司薪資報酬委員會任期屆滿","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2025-05-19 16:59，「公告本公司薪資報酬委員會任期屆滿」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2025-05-19-1658-1vrzia3","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2025-05-19","time":"16:58:19","subject":"公告本公司成立審計委員會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2025-05-19 16:58，「公告本公司成立審計委員會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2025-05-19-1656-1e3k2h0","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2025-05-19","time":"16:56:38","subject":"公告本公司114年股東常會改選董事及獨立董事(三分之一以上董事發生變動)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2025-05-19 16:56，「公告本公司114年股東常會改選董事及獨立董事(三分之一以上董事發生變動)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2025-05-19-1655-nhqhiz","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2025-05-19","time":"16:55:09","subject":"公告本公司114年度股東常會決議通過解除新任董事競業禁止之限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2025-05-19 16:55，「公告本公司114年度股東常會決議通過解除新任董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2025-05-19-1651-13dz8u4","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-19","time":"16:51:09","subject":"公告本公司114年股東常會解除新任董事及其代表人競業禁止之限制","clause":"第22款","fact_date":"2025-05-19","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2025-05-19 16:51，「公告本公司114年股東常會解除新任董事及其代表人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2025-05-19-1650-1mp68o2","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-19","time":"16:50:41","subject":"公告本公司114年股東常會補選一席法人董事","clause":"第6款","fact_date":"2025-05-19","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2025-05-19 16:50，「公告本公司114年股東常會補選一席法人董事」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6810-2025-05-19-1649-ds864w","company_id":"6810","company":"新穎生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-19","time":"16:49:54","subject":"公告本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-05-19","cite_as":"公開資訊觀測站重大訊息：新穎生醫（6810），2025-05-19 16:49，「公告本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4747-2025-05-19-1644-d9bwy4","company_id":"4747","company":"強生*","market":"上櫃","industry":"生技醫療","date":"2025-05-19","time":"16:44:44","subject":"公告本公司114年度股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：強生*（4747），2025-05-19 16:44，「公告本公司114年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8436-2025-05-19-1434-10yb8rh","company_id":"8436","company":"大江","market":"上櫃","industry":"生技醫療","date":"2025-05-19","time":"14:34:17","subject":"本公司受邀參加元富證券舉辦之法人說明會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大江（8436），2025-05-19 14:34，「本公司受邀參加元富證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4194-2025-05-19-1430-1asmasq","company_id":"4194","company":"禾生技","market":"興櫃","industry":"生技醫療","date":"2025-05-19","time":"14:30:04","subject":"本公司114年股東常會重要決議事項","clause":"第15款","fact_date":"2025-05-19","cite_as":"公開資訊觀測站重大訊息：禾生技（4194），2025-05-19 14:30，「本公司114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6861-2025-05-19-1420-1le4xfe","company_id":"6861","company":"睿生光電","market":"上市","industry":"生技醫療","date":"2025-05-19","time":"14:20:30","subject":"更正公告本公司董事會決議員工認股權憑證轉換普通股增資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：睿生光電（6861），2025-05-19 14:20，「更正公告本公司董事會決議員工認股權憑證轉換普通股增資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}